A Systematic Review on the Safety and Efficacy of PCSK9 Inhibitors in Lowering Cardiovascular Risks in Patients With Chronic Kidney Disease

Cardiovascular events caused by dyslipidemia are one of the leading causes of death in patients with Chronic Kidney Disease (CKD). Statins are the first line of treatment for patients with hyperlipidemia and in the treatment regimen for patients with CKD. Therefore, the introduction of Proprotein Co...

Descripción completa

Detalles Bibliográficos
Autores principales: Igweonu-Nwakile, Emmanuelar O, Ali, Safina, Paul, Salomi, Yakkali, Shreyas, Teresa Selvin, Sneha, Thomas, Sonu, Bikeyeva, Viktoriya, Abdullah, Ahmed, Radivojevic, Aleksandra, Abu Jad, Anas A, Ravanavena, Anvesh, Ravindra, Chetna, Balani, Prachi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477547/
https://www.ncbi.nlm.nih.gov/pubmed/36128564
http://dx.doi.org/10.7759/cureus.29140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477547/
https://www.ncbi.nlm.nih.gov/pubmed/36128564
http://dx.doi.org/10.7759/cureus.29140

Ejemplares similares